Nonalcoholic fatty liver disease (NAFLD) has become highly prevalent, now considered the most common liver disease in the western world. Approximately one-third of patients with NASH develop non-alchoholic steatohepatitis (NASH), histologically defined by lobular and portal inflammation, and accompanied by marked oxidative stress. Patients with NASH are at increased risk for cirrhosis and hepatocellular carcinoma, and diagnosis currently requires invasive biopsy. In animal models of NASH, particularly the methionine-choline deficient (MCD) model, profound changes are seen in redox enzymes and key intracellular antioxidants. To study antioxidant status in NASH non-invasively, we applied the redox probe hyperpolarized [1-13 C] dehydroascorbic acid (HP DHA), which is reduced to Vitamin C (VitC) rapidly in the normal liver. In MCD mice, we observed a significant decrease in HP DHA to VitC conversion that accompanied hepatic fat deposition. When these animals were subsequently placed on a normal diet, resonance ratios reverted to those seen in control mice. These findings suggest that HP DHA, a potentially clinically translatable imaging agent, holds special promise in imaging NASH and other metabolic syndromes, to monitor disease progression and response to targeted therapies.
. Reactive oxygen species (ROS) can directly damage the cell via membrane lipid peroxidation, and exert redox-dependent metabolic alterations 6 . These metabolic changes are enforced by regulation of key enzymes, redox-dependent post-translational protein modifications, and control of nuclear receptors including the peroxisome proliferator-activated receptor (PPAR), proliferator-activated receptor-gamma coactivator-1 (PCG-1) and sterol response element binding protein (SREBP) families [7] [8] [9] . Changes in redox status have been explored in numerous animal models of NASH, including those harboring genetic defects (ob/ob), or generated by feeding animals an altered diet 10 . The model that best recapitulates the histopathological features of NASH is the methionine-choline deficient (MCD) dietary model, which is accompanied by steatohepatitis, inflammation, and oxidative stress 11, 12 . The dynamics of oxidative/nitrosative stress in the MCD model were recently studied at 2,4, and 6-week time-points showing reductions in liver catalase and superoxide dismutase (SOD) activities, and subtle but statistically significant elevations of total nitrates/nitrites (NO x ) 13 . Both metabolic and proteomic analyses have been performed on MCD mice, yielding a large number of correlates to the observed oxidative injury in NASH 14, 15 . The proteomic study conducted by Lee et al. by MALDI-TOF analysis showed that several of the differentially expressed proteins in MCD mice were related to redox homeostasis. These included proteins directly involved in the detoxification of reactive oxygen and reactive nitrogen species (glutathione peroxidase, superoxide dismutase and glutathione S-transferase), proteins functioning in cellular protection against oxidative stress (peroxiredoxins), and the microsomal enzyme cytochrome P450 2E1 (CYP2E1). The study showed a dramatic increase CYP2E1 in MCD-fed mice compared to normal diet, reinforcing its role in generation of reactive oxygen species 16 . Finally, some studies have shown a decreased concentration of reduced glutathione (GSH) in MCD-fed mice 13, 17, 18 , although this decrease was not observed at two weeks 13 . Given the importance of oxidative stress in promoting hepatic injury in NASH, we studied the MCD-fed mice using a new spectroscopic method, namely magnetic resonance spectroscopy (MRS) using hyperpolarized [1- 13 C] dehydroascorbic acid (HP DHA), the oxidized form of Vitamin C (VitC) as an in vivo redox sensor 19 . Hyperpolarized 13 C MRS is a relatively new technique by which the spin polarization of a nucleus is enhanced by several orders of magnitude (up to 10 5 ) thereby allowing real-time study of in vivo metabolism 20, 21 . Recently, the technique has been used in prostate cancer patients, demonstrating its potential for translation into routine clinical practice 22 . We developed HP DHA to study the changes in redox homeostasis that accompany cancer and other diseases (Fig. 1) . HP DHA is transported rapidly into cells via glucose transporters (predominantly GLUT 1,3,4) and reduced to VitC in both cell and animal models 19, 23 . This conversion is believed to occur in a GSH-dependent manner, catalyzed by number of enzymes including glutaredoxin, protein disulfide isomerase, and glutathione transferases [24] [25] [26] [27] . We have also observed decreased HP DHA to VitC conversion in a model of diabetic nephropathy using db/db mice, and correlated this finding both to decreased GSH and increased NADPH oxidase 4 (Nox4) expression, reflecting increased superoxide generation 28 . For these studies, the rate of HP DHA to VitC conversion is best characterized by the resonance ratios derived from in vivo 13 C spectra, for example VitC/DHA or VitC/VitC + DHA. This conversion occurs within seconds in many tissues, reflecting rapid reduction of HP DHA by the cellular antioxidant network.
In the present study, we investigated NASH in the MCD-diet murine model using HP DHA and correlated spectroscopic data with hepatic steatosis. Fat accumulation in the liver was demonstrated both histologically and using 1 H MRI fat-water imaging at ultra high-field (14 T). MCD-diet mice were also studied following return to a normal diet (MCDr or "recovery" group). Rapid imaging using HP DHA in a rodent model of NASH provided a means of demonstrating oxidative stress non-invasively and the showing the restoration of liver cell redox capacity in MCDr mice.
Results

MCD-fed mice showed significant lipid accumulation at two weeks as evaluated by
1 H MRI at 14 T and histologic staining. Animals fed the MCD-diet were characterized by decreased body weight and liver size at two weeks, consistent with prior reports (Fig. 2A) . In the MCD group, the average hepatic volume was 0.57 ± 0.15 cm 3 (0.69 ± 0.17 cm 3 in the control group) and the average weight was 22.5 ± 3.8 g (30.8 ± 2.9 g in the control group), representing a 27% decrease (p < 0.05). The presence of oxidative injury in MCD mice was demonstrated via a catalase activity assay, and anti 8-OHdG monoclonal antibody staining ( Figure Supp Fig. 1 ). These studies were consistent with prior reports showing decreased catalase activity and increased 8-OHdG in MCD mice 13, 29 . Fat content of the liver was investigated by 1 H MRI, routine histology, and specialized staining. Steatosis was first demonstrated in vivo using 1 H MRI fat-water technique 30 , showing a significant increase in hepatic fat content (Fig. 2B, C) . In the MCD group, the hepatic fat content was 50.3 ± 11.1%, versus 16.9 ± 5.4% in the control group corresponding to a 3-fold increase (p < 0.05). In contrast, conventional T 2 -weighted sequences showed minimal differences in parenchymal signal between MCD and control groups. Following sacrifice, paraffin-embedded sections were studied using hematoxyln and eosin staining, showing predominantly microvesicular steatosis, without evidence of fibrosis (Fig. 2D ). This appearance is consistent with the study published by Jorgacevic et al., which explicitly studied the dynamics of histologic changes in MCD-fed animals 13 . The liver was also studied using Oil Red O dye, a lysochrome diazo dye used to stain triglycerides and lipids. Marked accumulation of the stain was observed for MCD-derived liver samples. Hyperpolarized 13 C dehydroascorbate spectroscopy reveals decreased HP DHA to VitC conversion in MCD-fed mice relative to controls. The redox sensor HP DHA was used to evaluate altered redox capacity in MCD-diet mice, using a ratiometric, 3D spectroscopic technique. In this case a single time-point 13 C magnetic resonance spectroscopic imaging (MRSI) study was performed to detect HP DHA to VitC conversion. Following intravenous injection of HP DHA, rapid conversion to VitC occurs in a matter of seconds, particularly in tissues with high exposure to oxidative stress including the brain, kidneys and liver. The rate of HP DHA to VitC conversion has been previously correlated with components of the redox network in animal models of cancer and diabetes 19, 23, 28 . As discussed previously, there is severe disruption of redox homeostasis in the MCD-deficient model, as evidenced by the downregulation of numerous enzymes involved in detoxification of reactive oxygen and reactive nitrogen species. We speculated that these numerous alterations might be detected by our non-invasive and potentially translatable HP MRS method.
In control mice, intravenous administration of HP DHA followed by 13 C MRSI revealed similar VitC/ VitC + DHA and VitC/DHA metabolite ratios to those previously reported. In contrast, these ratios were markedly lower in MCD mice as shown in Fig. 3 . The average VitC/VitC + DHA peak ratio was 0.49 ± 0.02 for the control group and 0.32 ± 0.03 for the MCD group (35% decrease, p < 0.05), while the average VitC/DHA metabolite ratio was 0.97 ± 0.07 for the control group and 0.49 ± 0.06 for the MCD group (49% decrease, p < 0.05) In all cases, anatomic T 2 -weighted 1 H imaging was performed during the same session to confidently assign voxels to the hepatic parenchyma.
MCD recovery mice showed a complete return to baseline by HP DHA MRS despite persistent elevated hepatic lipids. Having shown that the redox sensor HP DHA is responsive to hepatic injury in the MCD-diet model, we studied recovered mice following return to a normal diet (MCDr group). Numerous other modulations of the redox network in MCD mice have been studied, using artificial enzymes, vitamins, and other natural products. These therapies have included Mn-salen complexes, Vitamin C, Chunggan extract, hydrogen sulfide, hypotaurine and curcurmin 14, 15, [31] [32] [33] . In our study, mice originally fed the MCD-diet were allowed to recover for one week on a normal diet (n = 4, MCDr group). The animals were imaged by 13 C MRSI following injection of HP DHA with VitC/VitC + DHA and VitC/DHA resonance ratios again calculated for hepatic voxels. The results are shown in Fig. 4 , where representative HP spectra for the MCDr group are shown, and the metabolite ratios derived are compared to those for the MCD group. These data showed nearly identical metabolite ratios to those calculated for the control group, with the average VitC/VitC + DHA 0.47 ± 0.05 and the average VitC/DHA 0.95 ± 0.13 (p > 0.05 versus C group). Sacrificed MCDr mice showed mild histologic improvement in hepatic steatosis versus the MCD group, but significantly elevated lipid content relative to control animals (Fig. 4C ). Fat-water 1 H imaging of MCDr animals showed an average fat content of 34.0 ± 31.0%, representing a 2-fold increase versus the control group (p < 0.05), but no significant change versus MCD animals. In addition, the presence of thiols was assessed using the Mercury Orange technique showing depletion in MCD animals and recovery in MCDr mice (Fig. 4D ) 34 . These key findings lead to a model of MCD induced oxidative stress (Fig. 5) .
Discussion
This study demonstrated that 13 C MR spectroscopy using HP DHA is a sensitive indicator of metabolic alterations in the MCD-diet model of NASH. Given the extensive data implicating oxidative stress in this model, as well as what is known about the mechanism of HP DHA to VitC conversion, it is likely that altered redox status in MCD-mice is responsible for the observed differences in metabolite ratios. Oxidative stress in MCD-mice occurs via numerous mechanisms including decreased concentrations of intracellular reducing agents, decreased expression of key antioxidant defense enzymes (GPx, SOD, GST, and members of Prx family), and enhanced activity of microsomal enzymes especially CYP2E1. An interesting finding of our study was decreased overall thiol staining in the livers of MCD mice versus controls, in the absence of significant differences in GSH. This result may reflect the oxidation of protein thiols (for example thioredoxins), which some studies suggest represent the largest cellular redox pool 35 . Given the complexity of the intracellular redox network, it is difficult to identify which components are primarily responsible for in vivo HP DHA to VitC reduction. HP DHA has been previously studied in lymphoma (EL4) cells 23 , the transgenic adenocarcinoma of the mouse prostate (TRAMP) model 36 , and the db/db murine model of diabetic nephropathy 28 . These studies also analyzed specific components of the redox network and found correlations with the observed in vivo behavior of HP DHA. Given the results of these studies as well as what is known about DHA metabolism, HP DHA is probably best considered an oxidative challenge to tissues, with altered conversion seen in conditions for which the antioxidant defense system is compromised. Specific modulations of the redox network, via transgenic mice and gene silencing in cell culture, are currently being used to further elucidate the in vivo mechanisms of HP DHA and other novel redox probes. In addition, technical aspects of the HP DHA-MRI experiment are being refined, in particular to address toxicity in vivo 37 . Specifically, polarization and MR acquisition methods will require improvement, to allow the 13 C DHA dose reduction needed for patient studies.
In summary, HP DHA in a NASH model allowed us to assess the oxidative damage associated with disease progression and its normalization upon return to a normal diet. Moreover, in recovering mice this effect was reversed before the resolution of intrahepatic lipid deposits, suggesting that modulations of the antioxidant network and lipid accumulation may be non-synchronous in NASH. This finding has great implications both for potential use of HP DHA in the clinic as well as the development of novel therapeutic strategies to address NASH.
Methods
Animals and experimental design. All procedures were approved by the Institutional Animal Care and Use Committee. Veterinary services for the study were provided by the UCSF Laboratory Animal Resource Center (LARC) and all studies were performed in accordance with UCSF guidelines regarding animal housing, pain management, and euthanasia. The experiments used male FVB/NJ mice with an initial weight of 25-35 grams. The animals were kept under standard laboratory conditions (temperature 22 ± 2°C, relative humidity 50 ± 10%, 12 h/12 h light-dark cycle). All animals were fed with a control diet for at least 1 week (acclimatization period). 3 groups of animals were studied; Group 1: control group (C; n = 5); group 2: MCD-diet group fed for 2 weeks (MCD; n = 7); group 3: MCD-diet group fed for 2 weeks, followed by 1 week return to normal diet (MCDr; n = 4). Standard diet contained 2 g/kg of choline chloride and 3 g/kg of methionine, while the MCD diet had identical composition as the normal chow but without methionine and choline (Dyets Inc., Supp Fig. 2) . Animals in each group were subjected to HP DHA 13 C MRS, 1 H fat-water imaging, and histologic evaluation following sacrifice. Synthesis, preparation and polarization of [1-
13 C] dehydroascorbic acid. [1- 13 C] DHA (Isotec, Miamisburg, OH) was synthesized using a published method, by air oxidation of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 19 . The frozen sample was dissolved in distilled water containing 0.3 mM EDTA.
Hyperpolarized
13
C magnetic resonance spectroscopic imaging. In vivo studies were performed using a 3T MRI scanner (GE Healthcare) equipped with the MNS (multinuclear spectroscopy) hardware package. The RF coil used in these experiments was a dual-tuned . Prior to 13 C studies, 3-plane T 2 -weighted images were acquired for anatomic localization (T E = 100 ms, T R = 4 s, 6 averages) using a standard fast spin echo sequence. These images were used to calculate liver volumes for the control, MCD, and MCDr groups. Single time-point 13 C MRSI studies were carried out as previously published 39 . 350 μ L of a hyperpolarized 15 mM [1-13 C] DHA solution were injected similar to previously described methods for [1- Fat-water imaging at 14T. For all groups (control, MCD and MCDr), high-resolution T 2 and fat-water imaging was conducted at 14T using a Varian WB600 micro-imager and 40 mm 1 H millipede coil (Varian Instruments, Palo Alto, CA). Lipid percentage maps were calculated from fat and water images acquired with a conventional spin-echo sequence using the Dixon method 30, 40 .
Histopathology/Activity assays. Liver tissues from the control, MCD and MCDr groups were studied using Hematoxylin and Eosin (H&E), Oil Red O, and Mercury Orange staining. Formalin-fixed, paraffin-embedded liver tissues were sectioned at 4 μ m and stained with Hematoxylin and Eosin; frozen tissues embedded in OCT (optimum cutting media) were sectioned at 10 μ m and stained for Oil Red O and Mercury Orange using standard protocols 34, 41 . Anti 8-OHdG staining was performed as reported previously 28 . Catalase activity was determined via a standard method on homogenized liver tissue 13 .
Data analysis and statistical considerations.
In vivo MRSI data were processed using custom software written in IDL 8 (ITT Visual Information Solutions) and Matlab 2009b (MathWorks). DHA and Vitamin C resonances were integrated and peak heights were used to calculate relevant ratios. In order to assign voxels to the liver, 100% of a given voxel corresponded to the tissue of interest as validated by the corresponding T 2 -weighted image. Metabolite ratios were calculated for individual voxels using HP 13 C DHA and Vitamin C resonances, using relative peak heights. Average metabolite ratios (VitC/VitC + DHA and VitC/DHA) for liver tissue in individual animals were then calculated, and these values averaged for control, MCD and MCDr groups. For all animals, the number of voxels (per animal) used to determine the VitC/VitC + DHA and VitC/DHA ratios in the liver ranged between 2-4. All statistics were calculated using JMP software (SAS Corporation, Cary, NC). Significance was reported using a two-sided Student's t-test for all comparisons and a p-value < 0.05. All data are reported as mean ± standard error, with corresponding error bars depicted in the Figures.
